Table 1 Patient characteristics
Belatacept (n = 4) | CsA (n = 3) | |||
|---|---|---|---|---|
Age, years | 74 | (68–78) | 66 | (29–71) |
Gender, M/F | 3/1 | 3/0 | ||
Bodyweight, kg | 63.1 | (58.7–85.6) | 92.3 | (75.7–96.0) |
Body mass index, kg/m2 | 22.9 | (18.6–28.0) | 26.7 | (23.1–26.9) |
Donor, DD/LD | 4/0 | 3/0 | ||
Previous transplants | 0 | 0 | ||
Dialysis pretransplant | 3 | 1 | ||
Observation day after transplantation (day 0) | ||||
Week 1 | 7 | (6–8) | 6 | (6–7) |
Week 2 | 14.5 | (13–15) | 16 | (14–20) |
Week 13 | 90.5 | (78–95) | 91 | (77–93) |
Number of HLA mismatches | ||||
Total | 2.5 | (2–3) | 1 | (0–3) |
DR | 0.5 | (0–1) | 1 | (0–1) |
Duration of cold ischemia (h) | 16.5 | (9.2–23.6) | 13.4 | (12.7–15.1) |
CMV serostatus | ||||
D+/R+ | 4 | 1 | ||
D+/R- | 0 | 2 | ||